News

Toxys' ToxTracker performed very well in large PoC study by Proctor & Gamble

A proof of concept study of 18 chemicals comparing in vitro micronucleus, ToxTracker and genomics-based methods
Toxys' ToxTracker performed very well in large PoC study by Proctor & Gamble

LS@W alumnus Eline van Beest announced as Dutch winner of the first Henri Termeer Transatlantic Connections Award

The winners of the first Henri Termeer Transatlantic Connections Award have just been announced live in front of an online audience at the Innovation for Health event.
LS@W alumnus Eline van Beest is the Dutch winner of the first Henri Termeer Transatlantic connections Award

Five teams kick-off new Venture Challenge Spring edition

Five teams will be working from June to increase the chances of their technological invention in life sciences & health reaching the market.
Five teams kick-off new Venture Challenge Spring edition

Bi/ond announces new product: The MUSbit™

The whole Bi/ond team is excited to announce their newest product: The MUSbit™
Bi/ond announces new product: The MUSbit™

NUTRIGUT consortium, coordinated by NutriLeads, wins Eurostars grant to develop next generation gut health ingredient

A consortium comprising Nutrileads (NL, coordinator), Ambiotis (FR), ProDigest (B) and Örebro University (SE) won a 3 years Eurostars grant for their innovative NUTRIGUT project.
Nutrileads

Award Ceremony Proefdiervrij Venture Challenge

On the 23rd of April the award ceremony for the Proefdiervrij Venture Challenge will take place. After weeks of hard work, we will find out which team will go home with the grand prize of 25.000 euros.
Award Ceremony Proefdiervrij Venture Challenge

Nice article in C2W (in Dutch) on Venture Challenge Winner AmbAgon

Drugging the undruggable. Esther Thole interviews Venture Challenge winner AmbAgon's founders  Luc Brunsveld en Christian Ottmann for C2W.
Nice article in C2W (in Dutch) on Venture Challenge Winner AmbAgon

Sirius Medical proudly announces first international implant

Sirius Medical, a start-up company developing Sirius Pintuition as an affordable, non-radioactive, point source localization technology that enables accurate surgical guidance in oncology is proud to announce the first international implants with the Sirius
sirius

Sirius Medical announces FDA clearance of Sirius Pintuition for Breast Cancer Surgery

Sirius Medical announces FDA clearance of Sirius Pintuition for Breast Cancer Surgery. This clearance paves the way for Sirius to launch its Pintuition System in the United States.
Sirius Medical announces FDA clearance of Sirius Pintuition for Breast Cancer Surgery

Scientific paper by NutriLeads shows that its plant-based RG-I food ingredients support immune function and modulate the microbiota

First scientific data showing immune supportive properties of plant-based RG-I derived from bell pepper and carrot. Study published in the “Nutrition, Immunity and Viral infection” special issue of the peer-reviewed jou
Scientific paper by NutriLeads shows that its plant-based RG-I food ingredients support immune function and modulate the microbiota